|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medical Oncology (M.de B., G.J.P., A.J.M., A.D.A., H.M.P.) and Rheumatology (R.O., B.A.C.D., G.J.) VU University Medical Center, Amsterdam, The Netherlands; and Department of Biology (Y.G.A.), The Technion, Haifa, Israel
Platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) and interleukin-8 (IL-8) are angiogenic factors produced by tumor infiltrating macrophages. Here, we show that prolonged exposure of human monocytic/macrophage THP1 and U937 cells to sulfasalazine, an anti-inflammatory drug and inhibitor of nuclear factor-
B (NF-
B), resulted in down-regulation of PD-ECGF/TP and IL-8 (mRNA, protein and activity) along with elimination of their induction by tumor necrosis factor-
and interferon-
. Concomitantly, sulfasalazine-exposed cells were markedly resistant to 5'-deoxyfluorouridine, the last intermediate of capecitabine requiring activation by PD-ECGF/TP. This is the first report suggesting that disruption of NF-
B-dependent signaling pathways can provoke a marked and sustained down-regulation of macrophage-related angiogenic factors. However, this may also negatively affect capecitabine efficacy.
Address correspondence to: Dr. Godefridus J. Peters, Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. E-mail: gj.peters{at}vumc.nl
This article has been cited by other articles:
![]() |
R. Oerlemans, J. Vink, B. A C Dijkmans, Y. G Assaraf, M. van Miltenburg, J. van der Heijden, I. Ifergan, W. F Lems, R. J Scheper, G. J L Kaspers, et al. Sulfasalazine sensitises human monocytic/macrophage cells for glucocorticoids by upregulation of glucocorticoid receptor {alpha} and glucocorticoid induced apoptosis Ann Rheum Dis, October 1, 2007; 66(10): 1289 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liekens, A. Bronckaers, A.-I. Hernandez, E.-M. Priego, E. Casanova, M.-J. Camarasa, M.-J. Perez-Perez, and J. Balzarini 5'-O-Tritylated Nucleoside Derivatives: Inhibition of Thymidine Phosphorylase and Angiogenesis Mol. Pharmacol., August 1, 2006; 70(2): 501 - 509. [Abstract] [Full Text] [PDF] |
||||